National Library of Medicine; Notice of Meeting, 48166-48167 [05-16211]
Download as PDF
<![CDATA[
48166
Federal Register / Vol. 70, No. 157 / Tuesday, August 16, 2005 / Notices
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Columbia Hotel,
10207 Wincopin Circle, Columbia, MD
21044.
Contact Person: Charles Joyce, PhD,
Review Branch, NHLBI, National
Institutes of Health, 6701 Rockledge
Drive, Room 7196, Bethesda, MD 20892,
301/435–0288.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: August 10, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–16213 Filed 8–15–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Children’s Study Advisory
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Children’s
Study Advisory Committee.
Date: September 20–21, 2005.
Time: September 20, 2005, 7:30 a.m. to
8:30 a.m.
Agenda: Registration.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Time: September 20, 2005, 8:30 a.m. to
adjournment.
Agenda: The primary objectives/topics of
this meeting will focus on ethical
considerations, genetics, and behavioral and
social sciences in the National Children’s
Study.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Time: September 21, 2005, 7:30 a.m. to
8:30 a.m.
Agenda: Registration.
VerDate jul<14>2003
18:02 Aug 15, 2005
Jkt 205001
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Time: September 21, 2005, 8:30 a.m. to
adjournment.
Agenda: Continuation of Committee
discussions.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Marion Balsam, MD,
Executive Secretary, National Children’s
Study Advisory Committee, 6100 Executive
Boulevard, Bethesda, MD 20892, 301–594–
9147.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS).
Dated: August 10, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–16215 Filed 8–15–05; 8:45 am]
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate intramural
site visit reports.
Place: National Institutes of Health,
Building 31, 31 Center Drive 2A48, Bethesda,
MD 20892. (telephone conference call.)
Contact Person: Yvonne T. Maddox, PhD.,
Deputy Director, National Institute of Child
Health, and Human Development, NIH, 9000
Rockville Pike MSC 7510, Building 31, Room
2A03, Bethesda, MD 20892, (301) 496–1848.
The notice is being published less than 15
days prior to the meeting due to the urgent
need to meet timing limitations imposed by
the intramural research review cycle.
Information is also available on the
Institute’s/Center’s home page: https://
www.nichd.nih.gov/about/nachhd.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: August 10, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–16216 Filed 8–15–05; 8:45 am]
BILLING CODE 4140–01–M
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Child Health and
Human Development Council.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The intramural programs
and projects and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the intramural programs and projects,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Child Health and Human Development
Council, NACHHD Subcommittee on
Planning and Policy.
Date: August 19, 2005.
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors, National
Library of Medicine.
The meeting will be open the public
as indicated below, with attendance
limited to space available. Individuals
who plan to attend and special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), title 5 U.S.C., as amended for
the review, discussion, and evaluation
of individual intramural programs and
projects conducted by the National
Library of Medicine, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
E:\FR\FM\16AUN1.SGM
16AUN1
Federal Register / Vol. 70, No. 157 / Tuesday, August 16, 2005 / Notices
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Library of Medicine,
National Center for Biotechnology
Information.
Date: October 25, 2005.
Open: 9 a.m. to 12 p.m.
Agenda: Program discussion.
Place: National Library of Medicine,
Building 38, Board Room, 2nd Floor, 8600
Rockville Pike, Bethesda, MD 20892.
Closed: 12 p.m. to 2 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Library of Medicine,
Building 38, Board Room, 2nd Floor, 8600
Rockville Pike, Bethesda, MD 20892.
Open: 2 p.m. to 5 p.m.
Agenda: Program discussion.
Place: National Library of Medicine,
Building 38, Board Room, 2nd Floor, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: David J. Lipman, MD,
Director, Natl Ctr for Biotechnology
Information, National Library of Medicine,
Department of Health and Human Services,
Building 38A, Room 8N805, Bethesda, MD
20894, 301–435–5985,
dlipman@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into the building by non-government
employees. Persons without a government
I.D. will need to show a photo I.D. and signin at the security desk upon entering the
building.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
Dated: August 10, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–16211 Filed 8–15–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Recambinant DNA Advisory Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
VerDate jul<14>2003
18:02 Aug 15, 2005
Jkt 205001
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Recombinant
DNA Advisory Committee.
Date: September 21, 2005.
Time: 8 a.m. to 6 p.m.
Agenda: The committee will review
and discuss selected human gene
transfer protocols as well as related data
management activities.
Place: Bethesda Marriott, 5151 Pooks
Hill Road, Bethesda, MD 20814.
Contact Person: Laurie Lewallen,
Advisory Committee Coordinator, Office
of Biotechnology Activities, National
Institutes of Health, 6705 Rockledge
Drive, Room 750, Bethesda, MD 20892–
7985, (301) 496–9838,
lewalla@od.nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www4.od.nih.gov/oba/, where an agenda
and any additional information for the
meeting will be posted when available.
OMB’s ‘‘Mandatory Information
Requirements for Federal Assistance
Program Announcements’’ (45 FR
39592, June 11, 1980) requires a
statement concerning the official
government programs contained in the
Catalog of Federal Domestic Assistance.
Normally NIH lists in its
announcements the number and title of
affected individual programs for the
guidance of the public. Because the
guidance in this notice covers virtually
every NIH and Federal research program
in which DNA recombinant molecule
techniques could be used, it has been
determined not to be cost effective or in
the public interest to attempt to list
these programs. Such a list would likely
require several additional pages. In
addition, NIH could not be certain that
every Federal program would be
included as many Federal agencies, as
well as private organizations, both
national and international, have elected
to follow the NIH Guidelines. In lieu of
the individual program listing, NIH
invites readers to direct questions to the
information address above about
whether individual programs listed in
the Catalog of Federal Domestic
assistance are affected.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
48167
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: August 9, 2005.
Anthony M. Coehlo, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–16210 Filed 8–15–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (U.S.C. Appendix 2), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Protection
Against Doxorubicin-Induced
Cardiomyopathy.
Date: August 16, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone conference call).
Contact Person: Anshumali Chaudhari,
PhD, Scientific Review Administrator, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4124,
MSC 7802, Bethesda, MD 20892, (301) 435–
1210, chaudhaa@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business Grant Applications: Immunology.
Date: August 24, 2005.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\16AUN1.SGM
16AUN1
]]>Agencies
[Federal Register Volume 70, Number 157 (Tuesday, August 16, 2005)]
[Notices]
[Pages 48166-48167]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-16211]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Board of Scientific Counselors, National Library of Medicine.
The meeting will be open the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and special assistance, such as sign language interpretation or other
reasonable accommodations, should notify the Contact Person listed
below in advance of the meeting.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Library of Medicine, including consideration of personnel
qualifications and performance, and the competence of individual
investigators, the disclosure of which would
[[Page 48167]]
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Library of Medicine, National Center for Biotechnology Information.
Date: October 25, 2005.
Open: 9 a.m. to 12 p.m.
Agenda: Program discussion.
Place: National Library of Medicine, Building 38, Board Room,
2nd Floor, 8600 Rockville Pike, Bethesda, MD 20892.
Closed: 12 p.m. to 2 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Library of Medicine, Building 38, Board Room,
2nd Floor, 8600 Rockville Pike, Bethesda, MD 20892.
Open: 2 p.m. to 5 p.m.
Agenda: Program discussion.
Place: National Library of Medicine, Building 38, Board Room,
2nd Floor, 8600 Rockville Pike, Bethesda, MD 20892.
Contact Person: David J. Lipman, MD, Director, Natl Ctr for
Biotechnology Information, National Library of Medicine, Department
of Health and Human Services, Building 38A, Room 8N805, Bethesda, MD
20894, 301-435-5985, dlipman@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance into the building by non-government
employees. Persons without a government I.D. will need to show a
photo I.D. and sign-in at the security desk upon entering the
building.
(Catalogue of Federal Domestic Assistance Program Nos. 93.879,
Medical Library Assistance, National Institutes of Health, HHS)
Dated: August 10, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-16211 Filed 8-15-05; 8:45 am]
BILLING CODE 4140-01-M
